Philip Morris International Inc. Files 2023 Annual Report on Form 10-K

TL;DR

<b>Philip Morris International Inc. has filed its 2023 annual report (10-K) detailing its financial performance and business operations.</b>

AI Summary

Philip Morris International Inc. (PM) filed a Annual Report (10-K) with the SEC on February 8, 2024. Philip Morris International Inc. filed its 2023 Form 10-K on February 8, 2024. The filing covers the fiscal year ending December 31, 2023. The company's principal business is cigarettes. The filing includes detailed financial information and risk factors. Philip Morris International Inc. is incorporated in Virginia.

Why It Matters

For investors and stakeholders tracking Philip Morris International Inc., this filing contains several important signals. This 10-K filing provides a comprehensive overview of Philip Morris International's financial health, operational strategies, and potential risks for the fiscal year 2023, crucial for investors and analysts. The detailed information on revenue segments, debt, and executive compensation offers insights into the company's strategic direction and management's performance in the evolving tobacco and nicotine market.

Risk Assessment

Risk Level: medium — Philip Morris International Inc. shows moderate risk based on this filing. The company operates in the highly regulated tobacco industry, facing ongoing scrutiny and potential changes in consumer behavior and government policies, as indicated by the extensive risk factors section in the 10-K.

Analyst Insight

Review the detailed financial statements and risk factors in the 10-K to assess Philip Morris International's performance and future outlook, particularly concerning its transition to reduced-risk products.

Key Numbers

• 2023-12-31 — Fiscal Year End (The end date of the reporting period for the 10-K.)
• 2024-02-08 — Filing Date (The date the 10-K was filed with the SEC.)

Key Players & Entities

• Philip Morris International Inc. (company) — Filer and subject of the 10-K filing.
• 2023 (date) — Fiscal year covered by the 10-K report.
• 2024-02-08 (date) — Filing date of the 10-K.
• Virginia (location) — State of incorporation for Philip Morris International Inc.
• CIGARETTES (industry) — Standard Industrial Classification for the company.

Forward-Looking Statements

• PMI will likely refinance its 2024 maturing debt, potentially at higher interest rates given the current economic environment. (Philip Morris International Inc.) — medium confidence, target: 2024-12-31
• The company's interest expense will increase in the coming years as lower-rate debt matures and is replaced. (Philip Morris International Inc.) — medium confidence, target: 2025-12-31

FAQ

Risk Factors

• Extensive Regulation [high — regulatory]: The company operates in a highly regulated industry, facing potential changes in laws and regulations related to tobacco and nicotine products.
• Changing Consumer Preferences [medium — market]: Shifts in consumer preferences towards potentially less harmful alternatives or reduced consumption could impact sales volumes.
• Supply Chain Disruptions [medium — operational]: The company is subject to risks associated with global supply chains, including potential disruptions affecting manufacturing and distribution.

Industry Context

Philip Morris International operates within the global tobacco and nicotine products industry, a sector characterized by significant regulatory oversight and evolving consumer trends towards reduced-risk alternatives.

Regulatory Implications

The tobacco industry is subject to stringent regulations worldwide, including advertising restrictions, taxation, and product standards, which can significantly impact market dynamics and profitability.

What Investors Should Do

1. Analyze the company's revenue breakdown by product category and geographic region to understand growth drivers and market penetration.
2. Evaluate the company's debt structure and cash flow statements to assess financial stability and ability to fund operations and investments.
3. Scrutinize the risk factors section for potential headwinds and the company's mitigation strategies, especially concerning regulatory changes and product innovation.

Key Dates

• 2023-12-31: Fiscal Year End — Marks the end of the reporting period for the 10-K.
• 2024-02-08: 10-K Filing Date — Official submission date of the annual report to the SEC.

Year-Over-Year Comparison

This is the initial filing of the 2023 Form 10-K, providing the latest annual financial and operational data for Philip Morris International Inc.

Key Financial Figures

• $12.5 billion — products. Since 2008, we have invested $12.5 billion to develop, scientifically substantiate

Filing Documents

• pm-20231231.htm (10-K) — 4340KB
• pm-ex43_123123xq4.htm (EX-4.3) — 27KB
• pmi-exhibit44x10xk2023.htm (EX-4.4) — 114KB
• exhibit1028.htm (EX-10.28) — 105KB
• exhibit1033.htm (EX-10.33) — 2KB
• exhibit1091.htm (EX-10.91) — 56KB
• exhibit1092.htm (EX-10.92) — 58KB
• exhibit1093.htm (EX-10.93) — 53KB
• exhibit1094.htm (EX-10.94) — 57KB
• exhibit1095.htm (EX-10.95) — 63KB
• exhibit1096.htm (EX-10.96) — 56KB
• exhibit1097.htm (EX-10.97) — 60KB
• redactedsettlementagreement.htm (EX-10.98) — 1322KB
• pm-ex21_123123xq4.htm (EX-21) — 140KB
• pm-ex23_123123xq4.htm (EX-23) — 4KB
• pm-ex311_123123xq4.htm (EX-31.1) — 11KB
• pm-ex312_123123xq4.htm (EX-31.2) — 11KB
• pm-ex321_123123xq4.htm (EX-32.1) — 4KB
• pm-ex322_123123xq4.htm (EX-32.2) — 4KB
• exhibit97.htm (EX-97) — 46KB
• pm-20231231_g1.jpg (GRAPHIC) — 152KB
• pm-20231231_g10.jpg (GRAPHIC) — 54KB
• pm-20231231_g11.jpg (GRAPHIC) — 53KB
• pm-20231231_g12.jpg (GRAPHIC) — 47KB
• pm-20231231_g13.jpg (GRAPHIC) — 33KB
• pm-20231231_g14.jpg (GRAPHIC) — 23KB
• pm-20231231_g15.jpg (GRAPHIC) — 26KB
• pm-20231231_g2.jpg (GRAPHIC) — 51KB
• pm-20231231_g3.jpg (GRAPHIC) — 32KB
• pm-20231231_g4.jpg (GRAPHIC) — 32KB
• pm-20231231_g5.jpg (GRAPHIC) — 51KB
• pm-20231231_g6.jpg (GRAPHIC) — 54KB
• pm-20231231_g7.jpg (GRAPHIC) — 53KB
• pm-20231231_g8.jpg (GRAPHIC) — 47KB
• pm-20231231_g9.jpg (GRAPHIC) — 51KB
• 0001413329-24-000013.txt (&nbsp;) — 27006KB
• pm-20231231.xsd (EX-101.SCH) — 152KB
• pm-20231231_cal.xml (EX-101.CAL) — 191KB
• pm-20231231_def.xml (EX-101.DEF) — 925KB
• pm-20231231_lab.xml (EX-101.LAB) — 1756KB
• pm-20231231_pre.xml (EX-101.PRE) — 1237KB
• pm-20231231_htm.xml (XML) — 4205KB

Risk Factors

Item 1A. Risk Factors 7

Unresolved Staff Comments

Item 1B. Unresolved Staff Comments 19

Cybersecurity 19

Item 1C. Cybersecurity 19

Properties

Item 2. Properties 21

Legal Proceedings

Item 3. Legal Proceedings 21

Mine Safety Disclosures

Item 4. Mine Safety Disclosures 21 PART II

Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 21

[Reserved]

Item 6. [Reserved] 24

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations 24

Quantitative and Qualitative Disclosures About Market Risk

Item 7A. Quantitative and Qualitative Disclosures About Market Risk 78

Financial Statements and Supplementary Data

Item 8. Financial Statements and Supplementary Data 79

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 151

Controls and Procedures

Item 9A. Controls and Procedures 151

Other Information

Item 9B. Other Information 151

Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 151

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 151 PART III

Directors, Executive Officers and Corporate Governance

Item 10. Directors, Executive Officers and Corporate Governance 151

Executive Compensation

Item 11. Executive Compensation 154

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 154

Certain Relationships and Related Transactions, and Director Independence

Item 13. Certain Relationships and Related Transactions, and Director Independence 154

Principal Accounting Fees and Services

Item 14. Principal Accounting Fees and Services 154 PART IV

Exhibits and Financial Statement Schedules

Item 15. Exhibits and Financial Statement Schedules 155

Signatures

Signatures 162 In this report, "PMI," "we," "us" and "our" refers to Philip Morris International Inc. and its subsidiaries. Trademarks and service marks in this report are the registered property of, or licensed by, the subsidiaries of Philip Morris International Inc. and are italicized. PART I

Business

Item 1. Business. General Development of Business General Philip Morris International Inc. is a Virginia holding company incorporated in 1987. We are a leading international tobacco company, actively delivering a smoke-free future and evolving our portfolio for the long term to include products outside of the tobacco and nicotine sector. Our current product portfolio primarily consists of cigarettes and smoke-free products, which include heat-not-burn, vapor, and oral nicotine products. Since 2008, we have invested $12.5 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. This investment includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. In November 2022, we acquired Swedish Match AB ("Swedish Match") – a leader in oral nicotine delivery – creating a global smoke-free combination led by the companies' IQOS and ZYN brands. The U.S. Food and Drug Administration (the "FDA") has authorized versions of our IQOS Platform 1 devices and consumables, and Swedish Match's General snus, as Modified Risk Tobacco Products ("MRTPs"). We describe the MRTP orders in more detail in the "Business Environment" section of Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations . In March 2008, we became a U.S. public company listed on the New York Stock Exchange and subject to the rules of the U.S. Securities and Exchange Commission (the "SEC"). In September 2021, we laid the foundation for our long-term growth ambitions beyond nicotine in wellness and healthcare, including the milestone acquisitions of Vectura Group plc and Fertin Pharma A/S, which provide essential capabilities for future product development. Now, through our Vectura Fertin Pha

View Full Filing

View this 10-K filing on SEC EDGAR